JP2002538789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002538789A5 JP2002538789A5 JP2000603397A JP2000603397A JP2002538789A5 JP 2002538789 A5 JP2002538789 A5 JP 2002538789A5 JP 2000603397 A JP2000603397 A JP 2000603397A JP 2000603397 A JP2000603397 A JP 2000603397A JP 2002538789 A5 JP2002538789 A5 JP 2002538789A5
- Authority
- JP
- Japan
- Prior art keywords
- klk
- nucleic acid
- protein
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000007523 nucleic acids Chemical class 0.000 description 25
- 108020004707 nucleic acids Proteins 0.000 description 15
- 102000039446 nucleic acids Human genes 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 description 10
- 125000003275 alpha amino acid group Chemical group 0.000 description 9
- 101000605514 Homo sapiens Kallikrein-13 Proteins 0.000 description 5
- 101000605520 Homo sapiens Kallikrein-14 Proteins 0.000 description 5
- 102100038315 Kallikrein-13 Human genes 0.000 description 5
- 102100038298 Kallikrein-14 Human genes 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 101001091379 Homo sapiens Kallikrein-5 Proteins 0.000 description 4
- 101001091356 Homo sapiens Kallikrein-9 Proteins 0.000 description 4
- 102100034872 Kallikrein-4 Human genes 0.000 description 4
- 102100034868 Kallikrein-5 Human genes 0.000 description 4
- 102100034876 Kallikrein-9 Human genes 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 108010024383 kallikrein 4 Proteins 0.000 description 4
- 101000605516 Homo sapiens Kallikrein-12 Proteins 0.000 description 3
- 102100038318 Kallikrein-12 Human genes 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 101100520152 Arabidopsis thaliana PIR gene Proteins 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12426099P | 1999-03-11 | 1999-03-11 | |
| US60/124,260 | 1999-03-11 | ||
| US12738699P | 1999-04-01 | 1999-04-01 | |
| US60/127,386 | 1999-04-01 | ||
| US14491999P | 1999-07-21 | 1999-07-21 | |
| US60/144,919 | 1999-07-21 | ||
| PCT/CA2000/000258 WO2000053776A2 (en) | 1999-03-11 | 2000-03-09 | Human kallikrein-like genes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002538789A JP2002538789A (ja) | 2002-11-19 |
| JP2002538789A5 true JP2002538789A5 (nl) | 2007-05-10 |
Family
ID=27383080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000603397A Withdrawn JP2002538789A (ja) | 1999-03-11 | 2000-03-09 | 新規なヒトカリクレイン−様遺伝子 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1159431A2 (nl) |
| JP (1) | JP2002538789A (nl) |
| AU (2) | AU3139900A (nl) |
| CA (2) | CA2362885A1 (nl) |
| WO (2) | WO2000053776A2 (nl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6943236B2 (en) | 1997-02-25 | 2005-09-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| EP1734051A3 (en) * | 1998-12-01 | 2007-09-12 | Genetech, Inc. | Composition and methods for the diagnosis of tumours |
| CA2360073C (en) | 1999-01-28 | 2011-01-18 | Gen-Probe Incorporated | Probes and primers for detecting prostate specific antigen (psa) in a biological sample |
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| WO2001025446A1 (en) * | 1999-10-07 | 2001-04-12 | Schering Aktiengesellschaft | Dna encoding prost 07 polypeptide |
| JP2004512540A (ja) | 2000-11-01 | 2004-04-22 | マウント・サイナイ・ホスピタル | 卵巣癌の検出 |
| AU2002246502A1 (en) * | 2000-11-17 | 2002-08-06 | Hyseq, Inc. | Nucleic acids and polypeptides |
| AUPR402201A0 (en) * | 2001-03-27 | 2001-04-26 | Queensland University Of Technology | Polynucleotides and polypeptides linked to cancer and/or benign tumours |
| WO2003039475A2 (en) * | 2001-11-07 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods of identifying and using modulators of fractalkine receptor |
| US20060159616A1 (en) * | 2002-08-28 | 2006-07-20 | Mount Sinai Hospital | Methods for detecting endocrine cancer |
| EP1664331A2 (en) * | 2003-08-30 | 2006-06-07 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with kallikrein 9 (klk9) |
| WO2005078123A1 (en) * | 2004-02-18 | 2005-08-25 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with kallikrein 5 (klk5) |
| US20130315891A1 (en) * | 2012-05-25 | 2013-11-28 | Matthew Charles | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
| HUE032613T2 (en) | 2012-06-04 | 2017-10-30 | Diamedica Therapeutics Inc | Human tissue kallikrein 1 is glycosylated isoforms |
| CA3011092A1 (en) * | 2016-01-12 | 2017-07-20 | Palleon Pharmaceuticals Inc. | Use of siglec-7 or siglec-9 antibodies for the treatment of cancer |
| US11857608B2 (en) | 2017-03-09 | 2024-01-02 | Diamedica Inc. | Dosage forms of tissue kallikrein 1 |
| CN112480237B (zh) * | 2019-09-12 | 2023-10-17 | 上海津曼特生物科技有限公司 | 一种融合蛋白及其制备方法和应用 |
| CN114414812B (zh) * | 2020-12-21 | 2022-09-20 | 华中科技大学同济医学院附属同济医院 | 生物标志物组合在制备暴发性心肌炎诊断试剂及暴发性心肌炎药物方面的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786148A (en) * | 1996-11-05 | 1998-07-28 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a novel prostate-specific kallikrein |
| WO2000012708A2 (en) * | 1998-09-01 | 2000-03-09 | Genentech, Inc. | Further pro polypeptides and sequences thereof |
| US6146845A (en) * | 1997-04-02 | 2000-11-14 | Smithkline Beecham Corporation | Polynucleotides encoding a sialoadhesin family member-2 (SAF-2) |
| EP0869178A1 (en) * | 1997-04-02 | 1998-10-07 | Smithkline Beecham Corporation | SAF-3, Sialoadhesin family member-3 |
| CA2347835A1 (en) * | 1998-12-01 | 2000-06-08 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
-
2000
- 2000-03-09 WO PCT/CA2000/000258 patent/WO2000053776A2/en not_active Application Discontinuation
- 2000-03-09 CA CA002362885A patent/CA2362885A1/en not_active Abandoned
- 2000-03-09 AU AU31399/00A patent/AU3139900A/en not_active Abandoned
- 2000-03-09 WO PCT/CA2000/000259 patent/WO2000053747A1/en active Application Filing
- 2000-03-09 AU AU31398/00A patent/AU3139800A/en not_active Abandoned
- 2000-03-09 CA CA002366087A patent/CA2366087A1/en not_active Abandoned
- 2000-03-09 EP EP00908878A patent/EP1159431A2/en not_active Withdrawn
- 2000-03-09 JP JP2000603397A patent/JP2002538789A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002538789A5 (nl) | ||
| AU734220B2 (en) | Cloning and characterization of napsin, an aspartic protease | |
| JP2628767B2 (ja) | ウレアーゼ活性を有するタンパク質をコードするヌクレオチド配列 | |
| EP0643770B1 (en) | Helicobacter pylori cytotoxin associated immunodominant antigen useful for vaccines and diagnostics | |
| JP2002516103A5 (nl) | ||
| EP0967279A1 (en) | Helicobacter pylori cytotoxin useful for vaccines and diagnostics | |
| JP2002508970A5 (nl) | ||
| JP2002521055A5 (nl) | ||
| JP2003532365A5 (nl) | ||
| JP2002502589A5 (nl) | ||
| JP2002518010A5 (nl) | ||
| WO2001021810B1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001021804B1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| FR2767337B1 (fr) | Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose | |
| CA2395617A1 (en) | Trichoderma reesei xylanase | |
| JP2001526035A5 (nl) | ||
| JPH11506905A (ja) | Ｈｅｌｉｃｏｂａｃｔｅｒ ｐｙｌｏｒｉ ＣａｇＩ領域 | |
| JP2002512005A5 (nl) | ||
| CN106929520A (zh) | 一种番茄斑萎病毒属病毒基因及其应用 | |
| JP2005535287A5 (nl) | ||
| MXPA01005728A (es) | Loci polimorficos que diferencian al escherichia coli 157:h7 de otras cepas. | |
| US20030124546A1 (en) | Fragments of nucleic acids specific to mycobacteria which are members of the M. tuberculosis complex and their applications for the detection and the differential diagnosis of members of the M. tuberculosis complex | |
| KR100425884B1 (ko) | 살모넬라 타이피의 특정 항원성 외부막 단백질을 코딩하는 디엔에이 서열 | |
| JP2004500802A (ja) | ピロコッカス・アビシのゲノム配列およびポリペプチド、そのフラグメントおよびその使用 | |
| NZ520600A (en) | Novel therapeutic compositions for treating infection by Lawsonia spp |